Inocucor Technologies Taps Biotech Veteran as CEO
September 4th, 2014
Montreal, Sept. 4, 2014—Biotechnology industry veteran Donald R. Marvin has joined Inocucor Technologies Inc., the Montreal-based ag biotech company that develops biological products and processes for agriculture, as President and CEO.
“Inocucor is a leading-edge clean tech company that is destined to make a great contribution to agricultural productivity. Marvin will help the company fully develop the commercial potential of its technology to meet the needs of today’s farmers,” said Andrée-Lise Méthot, founder and managing partner of Cycle Capital Management, inc. Cycle Capital, a Canadian Cleantech venture capital fund, has invested in Inocucor.
Marvin has been an entrepreneur and leader in the commercialization of new life sciences diagnostic and research technologies and products for more than 30 years. He most recently was President and CEO of Cairn Associates Inc., a biotechnology, life science and consumer products strategy development and financial advisory firm.
Prior to that, Marvin was the president and CEO of IdentiGEN, Inc., a leading provider of DNA-based solutions to the agriculture and food industries. He was a co-founder of Nasdaq-traded Orchid BioSciences, a pioneer in human DNA identity testing, where he served as its chief operating officer, chief financial officer and senior vice president of corporate development.
His expertise includes strategic planning, business development, technical administration and operations at PepsiCo, Abbott Laboratories and Bayer AG, as well as domestic and international marketing and sales for the clinical diagnostics subsidiary of Boehringer Ingelheim.
Named New Jersey’s CFO of the year in 2001, Marvin is an experienced fundraiser. He has raised over $300 million in private and public financings, and completed nearly a dozen M&A transactions. Marvin has served on the boards of several public and privately held companies and currently serves on the board of MicroBiome Therapeutics, Inc.
He earned a B.S. in microbiology from Ohio State University and an M.B.A. in organizational behavior and finance from Iona College.
